In News: Scientists in Germany have identified a drug, bemnifosbuvir (currently under trial for hepatitis C), that can block replication of the hepatitis E virus. If trials succeed, it may become the first effective treatment for hepatitis E infections.
- Bemnifosbuvir is an antiviral drug originally developed for the treatment of hepatitis C virus (HCV) infection.
- It belongs to the class of nucleotide analogues, which mimic natural building blocks of viral genetic material.
- By disrupting the virus’s genetic machinery, it prevents the virus from multiplying inside host cells.
- Recent studies show that it can also block replication of the Hepatitis E virus (HEV), indicating potential for repurposing.
- Â It has demonstrated strong efficacy in animal studies without damaging healthy cells, suggesting a favorable safety profile.
- The concept of drug repurposing (using existing drugs for new diseases) helps reduce time and cost in drug development.
- If clinical trials are successful, it could become the first specific antiviral treatment for Hepatitis E, which currently lacks targeted therapy.
La Excellence IAS Academy, the best IAS coaching in Hyderabad, known for delivering quality content and conceptual clarity for UPSC 2026 preparation.
FOLLOW US ON:
â—‰ YouTube : https://www.youtube.com/@CivilsPrepTeam
â—‰ Facebook: https://www.facebook.com/LaExcellenceIAS
â—‰ Instagram: https://www.instagram.com/laexcellenceiasacademy/
GET IN TOUCH:
Contact us at info@laex.in, https://laex.in/contact-us/
or Call us @ +91 9052 29 2929, +91 9052 99 2929, +91 9154 24 2140
OUR BRANCHES:
Head Office: H No: 1-10-225A, Beside AEVA Fertility Center, Ashok Nagar Extension, VV Giri Nagar, Ashok Nagar, Hyderabad, 500020
Madhapur: Flat no: 301, survey no 58-60, Guttala begumpet Madhapur metro pillar: 1524, Rangareddy Hyderabad, Telangana 500081
Bangalore: Plot No: 99, 2nd floor, 80 Feet Road, Beside Poorvika Mobiles, Chandra Layout, Attiguppe, Near Vijaya Nagara, Bengaluru, 560040